SBI Life growth and agency diversification offset near-term margin and cost pressure

Investment View and Valuation

ICICI Direct Research’s July 28, 2026 result update retained a measured view on SBI Life Insurance despite steady business execution and improving product and distribution diversification. The broker downgraded the stock to HOLD from BUY and reduced its target price to Rs 2,100 from Rs 2,200, valuing the company at 1.9 times FY28E embedded value.

ICICI Direct considers valuations relatively supportive, but sees limited near-term re-rating triggers because of margin pressure, elevated costs and regulatory uncertainty around bank-led distribution.

Healthy Q1FY27 Operating Performance

SBI Life Insurance reported healthy operating performance in Q1FY27. New business premium increased 23 per cent year-on-year to Rs 8,910 crore, supported by growth in both individual and group business. Individual rated premium rose 14 per cent year-on-year to Rs 3,970 crore, in line with management’s FY27 growth guidance of around 14–15 per cent.

Improving Product Mix and Protection Traction

Product diversification improved during the quarter. The ULIP share declined to around 61–62 per cent from approximately 65 per cent a year earlier, while the non-ULIP mix increased to 38 per cent from 34 per cent. Management intends to sustain the improved mix through FY27 and dynamically reprice non-par products according to yield movements.

• Guaranteed non-par savings grew 27 per cent year-on-year to Rs 970 crore.
• Individual par APE increased 35 per cent to Rs 240 crore.
• Pure protection grew 41 per cent, while individual protection APE increased 18 per cent to Rs 190 crore.
• Rider attachment rose to around 45–50 per cent of policies from approximately 35 per cent previously.
• Rider sum assured represented around 39 per cent of individual sum assured.

Distribution Diversification and Agency Expansion

Distribution is becoming more balanced beyond SBI and RRB bancassurance, which contributed around 47 per cent of total APE. SBI and RRB individual APE grew 10 per cent year-on-year to Rs 2,450 crore, while SBI branch productivity improved 7 per cent to around Rs 45 lakh.

Agency individual APE grew around 20 per cent to Rs 1,310 crore, supported by agent additions and productivity gains. SBI Life Insurance added more than 34,000 agents and 11 branches in Q1FY27, following more than 100 branch additions over the preceding three years under Agency 2.0 and Agency Next.

Other bank partnerships grew around 19 per cent, largely in non-ULIP products. The new J&K Bank corporate-agency partnership is expected to begin business in Q2FY27. Management expects agency and alternate channels to contribute more meaningfully to incremental growth, while SBI bancassurance remains the core franchise.

VNB Growth but Near-Term Margin Pressure

VNB increased 29 per cent year-on-year to Rs 1,410 crore, but VNB margin declined to 26.2 per cent from 26.8 per cent. Management attributed the decline mainly to an unusually high contribution from lower-margin group term insurance business and GST.

Excluding GST, VNB would have been Rs 1,470 crore, up 35 per cent year-on-year, with a 27.4 per cent margin. Management believes Q1FY27 likely marked the margin bottom and expects margins to move towards the upper end of its 26–28 per cent guidance range as individual-business contribution normalises.

However, group business was boosted by a sizeable group term insurance contract, which management cautioned should not be extrapolated.

Costs and Operating Monitorables

Costs remain a monitorable. The operating-expense ratio rose to 7.7 per cent from 6.3 per cent, while the total cost ratio increased to 12 per cent from 10.8 per cent. The increase reflected GST, higher stamp duty linked to increased sum assured, the labour-code impact and continued technology and distribution investment.

Management expects expenses to streamline over subsequent quarters and the GST year-on-year drag to largely fade after Q2FY27. Stamp-duty costs, however, will track protection and sum-assured growth.

Key Operating Indicators

Key Factors Affecting the Thesis

• Product mix improvement and recovery in VNB margins.
• Operating leverage and the pace of expense normalisation.
• Potential regulation affecting bank-led distribution and earnings.